patent_id,patent_date,patent_title,patent_num_times_cited_by_us_patents,cpc_subclass_ids
12428653,2025-09-30,Gene therapy for ceroid lipofuscinoses,0,A01K|A61K|A61P|C12N|C12Y
12422433,2025-09-23,Blood biomarker that predicts persistent cognitive dysfunction after concussion,0,G01N
12421495,2025-09-23,Compositions and methods for selective phagocytosis of human cancer cells,0,A61K|C12N
12419973,2025-09-23,Methods and compositions for treatment of disorders and diseases involving RDH12,0,A61K|A61P|C07H|C12N|C12Q
12419945,2025-09-23,Vaccines against Zika virus,0,A61K|A61P|C07K|C12N|Y02A
12416017,2025-09-16,Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration,0,A61K|A61P|C07K|C12N
12414973,2025-09-16,Antigenically stealthed oncolytic viruses,0,A61K|A61P|C07K|C12N
12410463,2025-09-09,Molecular beacons,0,C12Q
12410234,2025-09-09,Compositions and methods for retrieving tumor-related antibodies and antigens,0,A61K|A61P|C07K
12410232,2025-09-09,Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor,0,A61K|A61P|C07K|C12N
12405260,2025-09-02,Multiplexed detection of toxins using graphene-based aptasensors,0,G01N
12404431,2025-09-02,Adhesive hydrogels and uses thereof,0,A61K|B01J|C08L|C09J
12404314,2025-09-02,Switch costimulatory receptors,0,A61K|A61P|C07K
12403204,2025-09-02,Gene therapy for ocular disorders,0,A61K|A61P|C07K|C12N
12403195,2025-09-02,Sensitizing cells to proton radiation,0,A61K|A61N|A61P
12392747,2025-08-19,PH sensing technique based on graphene electrodes,0,G01N
12385065,2025-08-12,Gene therapy for treating citrullenemia,0,A61K|A61P|C12N|C12Y
12383581,2025-08-12,Compositions and methods for targeting CD13 and TIM-3 with CAR T cells to treat acute myeloid leukemia,0,A61K|A61P|C07K
12379343,2025-08-05,Scalable back-gated functionalized graphene field effect transistors for detection of DNA and other target molecules,0,B82Y|G01N
12378178,2025-08-05,Oleic acid derivatives as treatments for Friedreich ataxia and inhibitors of ferroptosis,0,A61P|C07C
12377415,2025-08-05,Photoactivated selective release (PHASR) of droplets from microwell arrays,0,B01L|B81B|G01N
12371666,2025-07-29,Nucleoside modified mRNA and uses thereof,0,A61K|C07K|C12N
12370547,2025-07-29,Magnetic separation filters for microfluidic devices,0,B01L|B03C|G01N
12370180,2025-07-29,P38 map kinase inhibitors for treating Friedreich's ataxia,0,A61K|A61P
12365653,2025-07-22,Small molecule inhibitors of lactate dehydrogenase and methods of use thereof,0,A61K|A61P|C07D
12364750,2025-07-22,Conserved region T cell vaccines for coronavirus and methods of use,0,A61K|A61P|C07K|C12N|C12Y
12359181,2025-07-15,Optimized GALC genes and expression cassettes and their use,0,A01K|A61K|A61P|C12N|C12Y
12351712,2025-07-08,Bijels and methods of making the same,0,A23P|A61K|A61L|A61Q|B01D|B01J|C08F|C08J|C08L
12350334,2025-07-08,Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer,0,A61K|C07K|C12N
12344843,2025-07-01,Altering gene expression in cart cells and uses thereof,0,A61K|A61P|C12N
12344657,2025-07-01,"CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell",0,A61K|A61P|C07K|C12N
12343339,2025-07-01,Bisaminoquinolines and bisaminoacridines compounds and methods of their use,0,A61K|A61P|C07D
12338287,2025-06-24,Treatment of cancer using a CD33 chimeric antigen receptor,0,A61K|A61P|C07K
12331317,2025-06-17,Compositions and methods for increasing megakaryocyte production,0,A61K|C12N
12330127,2025-06-17,Aqueous systems of at least two phases containing microcapsules and processes for manufacturing the same,0,A61K|B01J|C12N
12329816,2025-06-17,Immunotherapy with metabolic enzyme expression,0,A61K|A61P|C07K|C12N|C12Y
12329760,2025-06-17,Methods and compositions for targeting retinoic acid for solid tumor immunotherapy,0,A61K|A61P|C07K|G01N
12325756,2025-06-10,Use of trans-signaling approach in chimeric antigen receptors,0,A61K|A61P|C07K|C12N
12324927,2025-06-10,Methods and systems for photodynamic therapy calculations,0,A61B|A61N|G01N
12324842,2025-06-10,Compositions and methods for making antibody conjugates,0,A61K|C07K|C12N|C12Y
12304948,2025-05-20,Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia,0,A61K|C07K|C12N
12291707,2025-05-06,Modified immune cells having enhanced function and methods for screening the same,0,A61K|C07K|C12N
12291699,2025-05-06,Lung disease models on a chip,0,A61L|C08L|C12M|C12N|G01N|G09B
12286401,2025-04-29,Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity,0,A61P|C07D
12282028,2025-04-22,Atomic description of immune complex that causes heparin-induced thrombocytopenia,0,A61K|C07K|G01N
12281167,2025-04-22,Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs),0,A61K|A61P|C07K
12280108,2025-04-22,Vaccines having an antigen and interleukin-21 as an adjuvant,0,A61K|A61N|A61P|C07K|C12N|Y02A
12270809,2025-04-08,Method for the site-specific covalent cross-linking of antibodies to surfaces,0,A61K|C07K|G01N
12268735,2025-04-08,"Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same",0,A61K|A61P|C07K|C12N
12258379,2025-03-25,Compositions and methods for switchable CAR T cells using surface-bound sortase transpeptidase,0,A61K|A61P|C07K|C12N|C12Y
12251476,2025-03-18,Mechano-sensitive microcapsules for drug delivery,0,A61K|A61P|B01J
12240884,2025-03-04,Methods for improving the efficacy and expansion of immune cells,0,A61K|A61P|C07K|C12N
12240872,2025-03-04,"Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same",0,A61K|A61P|C07K|C12N
12234274,2025-02-25,Use of the CD2 signaling domain in second-generation chimeric antigen receptors,0,A61K|A61P|C07K|C12N
12227588,2025-02-18,Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias,0,A61K|A61P|C07K|C12N
12227555,2025-02-18,Use of gene editing to generate universal TCR re-directed t cells for adoptive immunotherapy,0,A61K|A61P|C07K
12226471,2025-02-18,Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus,0,A61K|A61P|C12N
12222346,2025-02-11,Stable nanopores and nanopore arrays for ionic and other measurements,0,B81C|G01N
12221615,2025-02-11,GLP-1 and use thereof in compositions for treating metabolic diseases,0,A61K|A61P|C07K|C12N
12215154,2025-02-04,Compositions and methods for targeting γδ T cells with chimeric antigen receptors,0,A61K|A61P|C07K
12215137,2025-02-04,Compositions and methods for T cell delivery of therapeutic molecules,0,A61K|A61P|C07K|C12N
12214038,2025-02-04,Compositions and methods for cancer immunotherapy,0,A61K|A61P
12214037,2025-02-04,Treatment of cancer using humanized anti-BCMA chimeric antigen receptor,0,A61K|A61P|C07H|C07K|C12N
12214014,2025-02-04,Methods for scar reduction by converting scar fibroblasts into adipocytes with hair follicle-derived signals,0,A61K|A61P|C12N
12203074,2025-01-21,Compositions and methods for treatment of dominant retinitis pigmentosa,0,A01K|C12N
12201625,2025-01-21,Single nucleotide polymorphic alleles of human DP-2 gene for detection of susceptibility to hair growth inhibition by PGD2,0,A61K|A61P|A61Q|C12Q
12196763,2025-01-14,Compositions and methods for predicting post-surgical cardiovascular events,0,G01N
12187809,2025-01-07,Proximity-based sortase-mediated protein purification and ligation,0,C07K|C12N
12186757,2025-01-07,Devices and methods for monitoring and quantifying nucleic acid amplification,0,B01L|C12Q
12186278,2025-01-07,Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy,0,A61K|A61P
12180254,2024-12-31,Factor H variants for treatment of disease,0,A61K|A61P|C07K|C12N
12163959,2024-12-10,"Extracellular vesicle proteins and their use for cancer diagnosis, predicting response to therapy, and treatment",0,G01N
12163160,2024-12-10,Scalable purification method for AAV1,0,B01D|B01J|C12N|G01N
12163119,2024-12-10,Methods and composition for gene delivery using an engineered viral particle,0,A61K|C07K|C12N
12162922,2024-12-10,Enhanced antigen presenting ability of RNA car T cells by co-introduction of costimulatory molecules,0,A61K|C07K|C12N|G01N|Y02A
12161709,2024-12-10,Compositions for inducing an immune response against zika virus,0,A61K|A61P|C12N|Y02A
12139550,2024-11-12,Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP),0,A61K|C07K|G01N
12138305,2024-11-12,Nucleoside-modified RNA for inducing an adaptive immune response,0,A61K|A61P|C07C|C07D|C08G|C12N
12134757,2024-11-05,Apparatus,0,A61K|C12M|C12N|G01N
12128136,2024-10-29,Compositions and methods for cardiac regeneration,0,A61K|A61P
12128069,2024-10-29,Treatment of cancer using chimeric antigen receptor and protein kinase a blocker,0,A61K|C07K|C12N
12122829,2024-10-22,Human alpha-folate receptor chimeric antigen receptor,0,A61K|C07K
12122820,2024-10-22,Method of redirecting t cells to treat HIV infection,0,A61K|A61P|C07K|C12N
12116418,2024-10-15,Disrupting tumor tissues by targeting fibroblast activation protein (FAP),0,A61K|A61P|C07K|C12N|C12Y
12116387,2024-10-15,Antimicrobial peptides,0,A01N|A01P|A61K|A61P|C07K
12111317,2024-10-08,"Flow cytometry-based platform for the detection, enumeration, and isolation of disseminated tumor cells in bone marrow aspirates",0,A61K|C07K|G01N
12110331,2024-10-08,Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated protein 4 (CTLA-4),0,A61P|C07K
12109258,2024-10-08,"Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections",0,A61K|A61P|C07K|C12N|Y02A
12104152,2024-10-01,2′F-ANA-LET7 mediated utrophin upregulation for DMD therapy,0,A61K|A61P|C07H|C12N
12103917,2024-10-01,Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof,0,A61K|A61P|C07D
12098190,2024-09-24,Humanized anti-C5 antibodies and uses thereof,0,A61K|A61P|C07K
12097500,2024-09-24,Apparatus and methods for monitoring of biomarkers in blood,0,A61B|B01L|G01N
12097267,2024-09-24,Methods and compositions for treatment of ocular disorders and blinding diseases,0,A61K|A61P|C12N
12089566,2024-09-17,Systems and methods for automated imaging and manipulation of small animals,0,A01K|A61B|B25J|C12M|G01N|G02B
12085565,2024-09-10,SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion,1,G01N
12077527,2024-09-03,Compositions and methods for inhibiting ACSS2,0,A61K|A61P|C07D
12072336,2024-08-27,Methods for single-cell prostate tissue classification and prediction of cancer progression,0,C12Q|G01N
12071474,2024-08-27,Monoclonal antibodies against alpha-synuclein fibrils,0,A61K|A61P|C07K|G01N
12070483,2024-08-27,Compositions and methods for treatment of acute lung injury,0,A61K|A61P|C07K
12059454,2024-08-13,"Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders",0,A61K|C07K|C12N|C12Y|Y02A
12054734,2024-08-06,Purification and purity assessment of RNA molecules synthesized with modified nucleosides,0,A61K|C07H|C07K|C12N|C12P
12049479,2024-07-30,"Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom",0,A61K|A61M|A61N|A61P|C07K|C12N|G01N
12029760,2024-07-09,Compositions and methods for gene editing in T cells using CRISPR/Cpf1,0,A61K|A61P|C12N
12029745,2024-07-09,Effects of LGM2605 on a primate model of asthma,0,A61K|A61P
12023386,2024-07-02,Composition for treatment of Crigler-Najjar syndrome,0,A61K|A61P|C12N|C12Y
12023376,2024-07-02,Conserved region T cell vaccines for coronavirus and methods of use,0,A61K|A61P|C07K|C12N|C12Y
12018279,2024-06-25,Micro-engineered models of the human eye and methods of use,0,C07K|C12M|C12N|G01N
11999794,2024-06-04,Human mesothelin chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11998598,2024-06-04,Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same,0,A61K|A61P|C07K|C12N|Y02A
11998331,2024-06-04,Use of micro-ribonucleic acid (miRNA) to diagnose transplant rejection and tolerance of immunosuppression therapy,0,A61B|C12N|C12Q|G16B|G16H
11993776,2024-05-28,Trans-splicing molecules,0,C07K|C12N
11992503,2024-05-28,Prostate-specific membrane antigen cars and methods of use thereof,0,A61K|A61P|C07K|C12N
11992478,2024-05-28,Methods of using androgen receptor inhibitors as cancer therapeutics,0,A61K
11987576,2024-05-21,"Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject",0,A61G|A61K|A61P|A61Q|C07D
11981731,2024-05-14,Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy,0,A61K|A61P|C07K|C12N
11980659,2024-05-14,"Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same",0,A61K|C07K|C12N|C12Y|Y02A
11970525,2024-04-30,Treatment of cancer using GFR alpha-4 chimeric antigen receptor,0,A61K|A61P|C07K
11958892,2024-04-16,Use of ICOS-based cars to enhance antitumor activity and car persistence,0,A61K|A61P|C07K|C12N
11951134,2024-04-09,Cationic platelet lysate compositions and related methods,0,A61K|A61P
11946028,2024-04-02,Fibrosis model on a chip,0,A61L|C08L|C12M|C12N|G01N|G09B
11938200,2024-03-26,Non-nutritive sweeteners and polyols as imaging agents,0,A61B|A61K|G01R
11931380,2024-03-19,Inhibition of diacylglycerol kinase to augment adoptive T cell transfer,0,A61K|C07K|C12N|C12Y
11925685,2024-03-12,DNA antibody constructs encoding anti-ZIKV envelope antibodies,0,A61K|A61P|C07K|C12N|Y02A
11925662,2024-03-12,Compositions and methods of enhancing anti-tumor response using hybrid neutrophils,0,A61K|A61P|C12N
11920130,2024-03-05,Modified immune cells having enhanced function and methods for screening for same,0,A61K|C07K|C12N
11920116,2024-03-05,Systems and methods for producing micro-engineered models of the human cervix,0,C12M|C12N
11919946,2024-03-05,Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy,0,C07K
11918586,2024-03-05,Treatment of skin lesions,0,A61K|A61P
11913963,2024-02-27,Atomic description of immune complex that causes heparin-induced thrombocytopenia,0,A61K|C07K|G01N
11913026,2024-02-27,"Bispecific cytotoxic lymphocyte or macrophage-redirecting autoantibodies, methods for production thereof and methods of treatment",0,A61K|A61P|C07K|C12N
11912978,2024-02-27,Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal,0,A61K|A61P|B03C|C07K|C12M|C12N
11912753,2024-02-27,Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens,0,A61K|C07K|C12N
11906511,2024-02-20,Methods and compositions for treating diseases associated with exhausted T cells,1,C12Q|G01N
11905321,2024-02-20,Compositions and methods of muscle specific kinase chimeric autoantibody receptor cells,0,A61K|A61P|C07K|C12N|C12Y
11903929,2024-02-20,Method for inhibiting dengue virus infection,0,A61K|A61P|Y02A
11897845,2024-02-13,Small molecule inhibitors of lactate dehydrogenase and methods of use thereof,0,A61K|A61P|C07D
11896654,2024-02-13,DNA monoclonal antibodies targeting checkpoint molecules,0,A61K|A61P|C07K|C12N|Y02A
11896614,2024-02-13,Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells,0,A61K|A61P|C07K|C12N|C12Y
11891425,2024-02-06,Thioamide-modified peptides and uses thereof,0,A61K|C07K
11890329,2024-02-06,AAV9-mediated gene therapy for treating mucopolysaccharidosis type I,0,A61K|A61P|C12N|C12Y
11890301,2024-02-06,Methods and compositions for cells expressing a chimeric intracellular signaling molecule,1,A61K|A61P|C07K|C12N
11884747,2024-01-30,Compstatin analogs with increased solubility and improved pharmacokinetic properties,0,A61K|C07K|C08G
11884716,2024-01-30,Compositions and methods of phospholipase A2 receptor chimeric autoantibody receptor T cells,0,A61K|A61P|C07K|C12N
11883484,2024-01-30,Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates,0,A61K|A61P|C07K|C12N
11883470,2024-01-30,Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof,0,A61K|A61P|C12N|C12P|C12Y
11879133,2024-01-23,Gene therapy for ocular disorders,0,A61K|A61P|C07K|C12N|C12Y
11878004,2024-01-23,Method for inhibiting Zika virus infection,0,A61K|A61P|Y02A
11873312,2024-01-16,Transcriptome in vivo analysis (TIVA) and transcriptome in situ analysis (TISA),0,B01J|C07F|C07H|C12N|C12Q
11872249,2024-01-16,Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain,0,A61K|A61P|C07K|C12N
11866764,2024-01-09,Method for testing and screening p38 MAP kinase modifiers,0,A61K|A61P|C07D|C12Q|G01N
11866725,2024-01-09,Optimized lentiviral transfer vectors and uses thereof,0,C07K|C12N
11865187,2024-01-09,Methods and compositions for treating metastatic breast cancer and other cancers in the brain,0,A61K|A61P|C07K|C12N
11865167,2024-01-09,Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor,1,A61K|A61P|C07K
11865166,2024-01-09,Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor,0,A61K|A61P|C07K
11851477,2023-12-26,DNA monoclonal antibodies targeting influenza virus,0,A61K|A61P|C07K
11850236,2023-12-26,Method for inhibiting Zika virus infection,0,A61K|A61P|Y02A
11846622,2023-12-19,Multiplexed detection of toxins using graphene-based aptasensors,0,G01N
11844830,2023-12-19,Vaccines for human papilloma virus and methods for using the same,0,A61K|A61N|A61P|C07K|C12N|Y02A
11827906,2023-11-28,Adeno-associated virus (AAV) clade f vector and uses therefor,0,A61K|C07K|C12N
11827898,2023-11-28,Gene therapy for ocular disorders,0,A01K|A61K|C07K|C12N
11827705,2023-11-28,Methods to protect transplanted tissue from rejection,0,A61K|A61P|C07K|C12N
11819539,2023-11-21,Gene therapy for treating Mucopolysaccharidosis type II,0,A61K|A61P|C12N|C12Y
11814613,2023-11-14,Lung disease models on a chip,1,A61L|C08L|C12M|C12N|G01N|G09B
11814412,2023-11-14,Artificial proteins and compositions and methods thereof,0,C07K|G01N
11813338,2023-11-14,Diagnosing and treating cancer,0,A61K
11807866,2023-11-07,"Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof",0,C12N
11802159,2023-10-31,Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs),0,A61K|A61P|C07K
11801314,2023-10-31,RNA containing modified nucleosides and methods of use thereof,1,A61K|A61P|C07H|C07K|C12N|C12Q|C12Y
11801298,2023-10-31,MERS-CoV vaccine,0,A61K|A61P|C12N
11800859,2023-10-31,Rat models for CMT2A that develop a progressive neuropathy,0,A01K|C12N|C12Y
11795423,2023-10-24,Micro-fabricated multi-well chips for long term automated imaging of C. elegans growth and behavior,0,B01L|C12M|C12N
11795240,2023-10-24,Enhancing activity of CAR T cells by co-introducing a bispecific antibody,1,A61K|A61P|C07K|C12N
11793887,2023-10-24,Gene therapy for treating peroxisomal disorders,0,A01K|A61K|A61P|C07H|C12N
11793872,2023-10-24,Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof,0,A61K|A61P|C07K|C12N
11786914,2023-10-17,Magnetic separation filters and microfluidic devices using magnetic separation filters,0,B01L|B03C|G01N
11786551,2023-10-17,Methods for treating heart disease via redirected T cell immunotherapies,0,A61K|A61P|C07K
11786186,2023-10-17,Super-resolution tomosynthesis imaging systems and methods,0,A61B|G01N
11779656,2023-10-10,Gene therapy for treating hemophilia A,0,A61K|A61P|C12N
11779644,2023-10-10,Sensitizing cells to proton radiation,1,A61K|A61N|A61P
11779570,2023-10-10,Method for inhibiting dengue virus infection,0,A61K|A61P|Y02A
11771719,2023-10-03,Methods and compositions for gene editing in hematopoietic stem cells,0,A61K|A61P|C12N
11766453,2023-09-26,Compositions and methods comprising prostate stem cell antigen (PSCA) chimeric antigen receptors (CARs),1,A61K|A61P|C07K|C12N
11766448,2023-09-26,Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer,0,A61K|A61P|C12N
11761959,2023-09-19,Blood biomarker that predicts persistent cognitive dysfunction after concussion,2,G01N
11752159,2023-09-12,Compositions and methods for suppressing or reducing systemic immune response in a subject,0,A61K|A61P
11747346,2023-09-05,Biomarkers predictive of cytokine release syndrome,1,A61K|A61P|C07K|C12Q|G01N
11738047,2023-08-29,Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof,1,A61K|A61P|C07K|C12N
11738004,2023-08-29,Indomethacin analogs for the treatment of castrate-resistant prostate cancer,0,A61K|C07D
11732246,2023-08-22,Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency,0,A61K|A61P|C12N|C12Y
11732245,2023-08-22,Scalable purification method for AAV9,0,B01D|B01J|C12N|G01N
11723989,2023-08-15,Gene therapy for mucopolysaccharidosis IIIB,0,A61K|A61P|C12N|C12Y
11723969,2023-08-15,"Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same",0,A61K|A61N|A61P|C07K|C12N
11723927,2023-08-15,Methods and composition for gene delivery using an engineered viral particle,0,A61K|C07K|C12N
11718685,2023-08-08,Compositions and methods for targeting stromal cells for the treatment of cancer,0,A61K|A61P|C07K|C12N
11708422,2023-07-25,Mitigation of lung injury,0,A61K|C07K
11680274,2023-06-20,Method of increasing the function of an AAV vector,0,A61K|A61P|C07K|C12N
11680207,2023-06-20,Direct mapping of local director field of nematic liquid crystals at the nanoscale,0,C09K|G01N|G02B
11673964,2023-06-13,Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias,1,A61K|A61P|C07K|C12N
11668721,2023-06-06,Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies,1,A61B|G01N
11667691,2023-06-06,Treatment of cancer using chimeric CD3 receptor proteins,0,C07K
11660332,2023-05-30,Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus,0,A61K|A61P|C12N
11649435,2023-05-16,Methods and compositions for cells expressing a chimeric intracellular signaling molecule,0,A61K|C07K|C12N
11648303,2023-05-16,Vaccines against zika virus,0,A61K|A61P|C07K|C12N|Y02A
11648270,2023-05-16,Methods for treating chronic lymphocytic leukemia (CLL),0,A61K|A61P|C12N|Y02A
11639335,2023-05-02,Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy,0,A61K|A61P|C07D|Y02A
11638747,2023-05-02,WT1 vaccine,0,A61K|A61P|C07K
11634700,2023-04-25,Hyperactive AID/APOBEC and hmC dominant TET enzymes,0,C12N
11630052,2023-04-18,Ultra-high throughput detection of fluorescent droplets using time domain encoded optofluidics,0,B01L|C12M|G01N|G06V
11629198,2023-04-18,Fusion proteins and antibodies targeting human red blood cell antigens,0,A61K|C07K|G01N|Y02A
11623927,2023-04-11,"Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules",0,A61P|C07D
11617817,2023-04-04,Biomaterials for enhanced implant-host integration,0,A61K|A61L
11609159,2023-03-21,"Systems, devices, and methods for agricultural sample collection",2,A01G|B64D|B64U|G01N
11597911,2023-03-07,Expansion of populations of T cells by the use of modified serum free media,0,A61K|C07K|C12N
11597778,2023-03-07,Human monoclonal autoantibodies to ADAMTS13 and uses thereof,0,A61K|C07K|C12Q|C12Y|G01N
11597754,2023-03-07,Use of the CD2 signaling domain in second-generation chimeric antigen receptors,2,A61K|A61P|C07K|C12N
11596679,2023-03-07,Hepatitis C virus gene sequences and methods of use therefor,0,A61K|A61P|C12N
11596678,2023-03-07,"Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same",1,A61K|A61P|C07K|C12N
11596636,2023-03-07,Tailored combinatorial epigenetic therapies for P53 gain-of-function tumors,0,A61K
11591614,2023-02-28,Gene therapy for ceroid lipofuscinoses,0,A01K|A61K|A61P|C12N|C12Y
11591404,2023-02-28,Treatment of cancer using a CD123 chimeric antigen receptor,0,A61K|A61P|C07K|C12N
11591298,2023-02-28,"Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use",0,A61K|A61P|C07D|Y02A
11584937,2023-02-21,Compositions and methods for controlling plant growth and development,0,C07K|C12N|C12Y
11578341,2023-02-14,Compositions useful in treatment of spinal muscular atrophy,1,A01K|A61K|A61P|C07K|C12N
11578137,2023-02-14,Anti-C5 antibodies and uses thereof,1,A61K|A61P|C07K
11578130,2023-02-14,Regulatable chimeric antigen receptor,0,A61K|A61P|C07K|C12N|C12Y
11578113,2023-02-14,Compositions and methods of chimeric autoantibody receptor T cells,0,A61K|C07K
11565001,2023-01-31,Adeno-associated virus virions with variant capsid and methods of use thereof,2,A61K|A61P|C07K|C12N
11565000,2023-01-31,Adeno-associated virus virions with variant capsid and methods of use thereof,2,A61K|A61P|C07K|C12N
11564996,2023-01-31,Gene therapy for ocular disorders,0,A61K|A61P|C07K|C12N
11559522,2023-01-24,Methods for enhancing liver regeneration,0,A61K|A61P
11555059,2023-01-17,LDLR variants and their use in compositions for reducing cholesterol levels,0,A61K|A61P|C07K|C12N
11554180,2023-01-17,Adeno-associated virus virions with variant capsid and methods of use thereof,2,A61K|A61P|C07K|C12N
11554147,2023-01-17,Gene therapy for treating familial hypercholesterolemia,0,A01K|A61K|A61P|C07K|C12N
11554113,2023-01-17,Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects,0,A61K|A61P
11549099,2023-01-10,Cell secreted minibodies and uses thereof,0,A61K|C07K|C12N
11542500,2023-01-03,TRIM11 for degradation of protein aggregates,0,A61K|A61P|C12N|G01N
11542488,2023-01-03,Sortase synthesized chimeric antigen receptors,1,C07K|C12N
11542282,2023-01-03,Low affinity poly(AD-ribose) polymerase 1 dependent cytotoxic agents,0,A61K|A61P|C07B|C07D|C07F|G01N
11535866,2022-12-27,Gene therapy for treating citrullenemia,1,A61K|A61P|C12N|C12Y
11535665,2022-12-27,AAV-mediated expression of anti-influenza antibodies and methods of use thereof,0,A61K|A61P|C07K|C12N
11535662,2022-12-27,CD28 compositions and methods for chimeric antigen receptor therapy,0,A61K|A61P|C07K|C12N
11530381,2022-12-20,Oxygen gradient hydrogel drug screening,0,C12M|G01N
11524999,2022-12-13,Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia,1,A61K|C07K|C12N
11499167,2022-11-15,Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby,0,A61K|A61P|C07K|C12N|C12Q|C12Y
11498954,2022-11-15,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11492580,2022-11-08,Method using a three-dimensional bioprocessor,0,A61K|C12M|C12N|G01N
11484552,2022-11-01,Use of trans-signaling approach in chimeric antigen receptors,1,A61K|A61P|C07K|C12N
11473131,2022-10-18,Methods for detecting genomic DNA methylation,0,C07H|C12P|C12Q
11473106,2022-10-18,Gene therapy for treating Wilson's disease,1,A01K|A61K|A61P|C07K|C12N
11471487,2022-10-18,Compositions and methods of stimulating and expanding T cells,0,A01N|A61K|A61P|C07K|C12N
11471443,2022-10-18,Anti-flavivirus compounds and methods of use,4,A61K|A61P|Y02A
11464841,2022-10-11,TERT immunogenic compositions and methods of treatment using the same,1,A61K|A61P|C07K|C12N|C12Y|Y02A
11459390,2022-10-04,Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor,0,A61K|A61P|C07K|C12N
11459295,2022-10-04,2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same,0,A61K|A61P|C07C
11453848,2022-09-27,Fibrosis model on a chip,0,A61L|C08L|C12M|C12N|G01N|G09B
11447769,2022-09-20,Modified immune cells having enhanced function and methods for screening for same,0,A61K|C07K|C12N
11446516,2022-09-20,Methods of increasing response to cancer radiation therapy,0,A61K|A61N|A61P|C07K
11446391,2022-09-20,Amphiphilic dye-coated inorganic nanoparticle clusters,0,A61K|A61P
11446369,2022-09-20,Compositions and methods comprising KLK3 or FOLH1 antigen,3,A61K|A61P|C07K|C12N|C12Y
11435362,2022-09-06,Atomic description of immune complex that causes heparin-induced thrombocytopenia,1,A61K|C07K|G01N
11434279,2022-09-06,Anti-factor D antibodies and uses thereof,0,A01K|A61K|A61P|C07K
11419925,2022-08-23,Cancer vaccines and methods of treatment using the same,0,A61K|A61P|C12N|C12Y
11415546,2022-08-16,Volatile organic compound-based diagnostic systems and methods,2,B82Y|G01N|H10K
11413340,2022-08-16,Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy,1,A61K|A61P
11407805,2022-08-09,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11407804,2022-08-09,Compositions and methods of chimeric autoantibody receptor T cells,0,A61K|C07K
11407803,2022-08-09,Compositions and methods of chimeric autoantibody receptor T cells,0,A61K|C07K
11407802,2022-08-09,Compositions and methods of chimeric autoantibody receptor T cells,0,A61K|C07K
11401527,2022-08-02,Compositions and methods useful for prophylaxis of organophosphates,0,A61K|C07K|C12N
11396663,2022-07-26,"Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor",0,A61K|A61P|C07K|C12N|C12Y
11390883,2022-07-19,"Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor",0,A61K|A61P|C07K|C12N|C12Y
11389547,2022-07-19,RNA containing modified nucleosides and methods of use thereof,1,A61K|A61P|C07H|C07K|C12N|C12Q|C12Y
11377669,2022-07-05,Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby,0,A61K|A61P|C07K|C12N|C12Q|C12Y
11377481,2022-07-05,SpyCatcher and SpyTag: universal immune receptors for T cells,0,A61K|C07K
11371041,2022-06-28,"Random RNA libraries, methods of generating same, and screening methods utilizing same",0,C12N
11369618,2022-06-28,"Compounds, compositions and methods for prevention and/or treatment of cancer",0,A61K|A61P|C07D|C07K
11359002,2022-06-14,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11357868,2022-06-14,"Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor",0,A61K|A61P|C07K|C12N|C12Y
11357867,2022-06-14,"Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor",0,A61K|A61P|C07K|C12N|C12Y
11357845,2022-06-14,Protein antigens for vaccinating against nontypeable Haemophilus influenzae,0,A61K|A61P
11345735,2022-05-31,Fully-human t-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein,0,A61P|C07K|C12N
11339436,2022-05-24,Methods for early identification of bone healing ability in injured patients,0,C12Q|G01N
11338247,2022-05-24,Method of stem-based drilling of ultrathin silicon nitride nanopores and nanopore arrays,0,B01D|C12Q|G01N|H01J
11337665,2022-05-24,Radiographic contrast agents for temporal subtraction and dual-energy x-ray imaging,1,A61B|A61K
11332754,2022-05-17,Codon optimization for increasing transgene expression in chloroplasts of higher seed plants,0,A61K|A61P|C07K|C12N|C12Y|Y02A
11332511,2022-05-17,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11327041,2022-05-10,pH sensing technique based on graphene electrodes,0,G01N
11325963,2022-05-10,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11324858,2022-05-10,Biomaterials for enhanced implant-host integration,1,A61K|A61L
11319358,2022-05-03,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11312784,2022-04-26,IgG binding peptides and multifunctional antigen-binding proteins comprising the same,0,A61K|A61P|C07K|G01N
11306134,2022-04-19,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11306133,2022-04-19,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,0,A61K|A61P|C07K|C12N
11305280,2022-04-19,Magnetic separation filters for microfluidic devices,1,B01L|B03C|G01N
11300640,2022-04-12,Protein reporters for ultrasensitive detection methods,0,A61K|C01B|G01R|G16H|Y02A
11299536,2022-04-12,Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer,3,A61K|C07K|C12N
11278619,2022-03-22,DNA antibody constructs and method of using same,0,A61K|A61P|C07K|C12N|G01N|Y02A
11274298,2022-03-15,RNA engineered T cells for the treatment of cancer,1,A61K|A61P|C07K|C12N
11274146,2022-03-15,Anti-C5a antibodies and uses thereof,0,A61K|C07K|C12N
11273227,2022-03-15,Compositions and methods useful in treating Stargardt's disease and other ocular disorders,0,A61K|A61P|C07K|C12N
11273219,2022-03-15,Toxicity management for anti-tumor activity of CARs,1,A61K|A61P|C12Q|G01N
11260358,2022-03-01,Aqueous systems of at least two phases containing microcapsules and processes for manufacturing the same,1,A61K|B01J|C12N
11253616,2022-02-22,Small molecules for dual function positron emission tomography (PET) and cell suicide switches,0,A61K|C12N|C12Y|G01N|Y02A
11253612,2022-02-22,Gene therapy for treating mucopolysaccharidosis type II,1,A61K|A61P|C12N|C12Q|C12Y
11248199,2022-02-15,Artificial placenta and methods of preparation,0,B01D|B81B|B81C|C12M|C12N|G01N
11247971,2022-02-15,Small molecule inhibitors of lactate dehydrogenase and methods of use thereof,2,A61K|A61P|C07D
11246819,2022-02-15,Compositions and methods for inhibiting biofilm deposition and production,0,A01N|A61K|A61P|A61Q|C12N|C12Y
11241506,2022-02-08,Composition for treatment of Crigler-Najjar syndrome,0,A61K|A61P|C12N|C12Y
11241496,2022-02-08,"Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same",0,A61K|A61P|C07K|C12N
11241490,2022-02-08,Nucleoside-modified RNA for inducing an immune response against zika virus,2,A61K|A61P|C12N|Y02A
11241487,2022-02-08,"Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders",0,A61K|C07K|C12N|C12Y|Y02A
11236177,2022-02-01,Proximity-based sortase-mediated protein purification and ligation,0,C07K|C12N
11236074,2022-02-01,"Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject",0,A61G|A61K|A61P|A61Q|C07D
11235040,2022-02-01,Acetylcholine receptor-specific immunosuppressive compositions and methods of treatment of myasthenia gravis,0,A61K|A61P
11220597,2022-01-11,Bijels and methods of making the same,0,A23P|A61K|A61L|A61Q|B01D|B01J|C08F|C08J|C08L
11220538,2022-01-11,Monoclonal antibodies against alpha-synuclein fibrils,0,A61K|A61P|C07K|G01N
11208661,2021-12-28,Altering gene expression in modified T cells and uses thereof,6,A61K|A61P|C12N
11208470,2021-12-28,DNA antibody constructs and method of using same,0,A61K|A61M|A61P|C07K|C12N|Y02A
11203758,2021-12-21,Altering gene expression in modified T cells and uses thereof,10,A61K|A61P|C12N
11197937,2021-12-14,Compositions for treatment of wet age-related macular degeneration,4,A61K|A61P|C07K|C12N
11197936,2021-12-14,Methods and compositions for treatment of disorders and diseases involving RDH12,1,A61K|A61P|C07H|C12N|C12Q
11197876,2021-12-14,Effects of LGM2605 on a primate model of asthma,1,A61K|A61P
11191847,2021-12-07,Gene therapy for treating hemophilia B,2,A61K|A61P|C07H|C12N
11191784,2021-12-07,Methods and composition for gene delivery using an engineered viral particle,4,A61K|C07K|C12N
11185294,2021-11-30,Super-resolution tomosynthesis imaging systems and methods,2,A61B|G01N
11180550,2021-11-23,Compositions and methods for treating cancer,0,A61K|A61P|C07K|C12N
11179458,2021-11-23,Immunogenicity of an optimized synthetic consensus DNA vaccine for porcine epidemic diarrhea virus,0,A61K|A61N|A61P|C07K|C12N
11179385,2021-11-23,Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions,0,A61K|A61P
11179379,2021-11-23,Compositions and methods for hemoglobin production,0,A61K|A61P|C12N
11162065,2021-11-02,Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal,8,A61K|A61P|B03C|C07K|C12M|C12N
11161907,2021-11-02,Car-expressing cells against multiple tumor antigens and uses thereof,5,A61K|A61P|C07K|C12N
11161865,2021-11-02,Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy,0,A61K|A61P|C07B|C07D|C07F|C12Q|G01N
11156608,2021-10-26,Method for the site-specific covalent cross-linking of antibodies to surfaces,3,A61K|C07K|G01N
11155608,2021-10-26,"Monoclonal antibodies against pathological alpha-synuclein, and methods using same",1,A61K|A61P|C07K|G01N
11149076,2021-10-19,"CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell",5,A61K|A61P|C07K|C12N
11142762,2021-10-12,U1 snRNP regulates gene expression and modulates oncogenicity,0,A61K|C12N
11141478,2021-10-12,Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof,0,A61K|A61P|C07K|C12N
11135313,2021-10-05,Intrathecal administration of adeno-associated-viral vectors for gene therapy,2,A61K|A61P|C07K|C12N|Y02A
11135284,2021-10-05,MERS-CoV vaccine,0,A61K|A61P|C12N
11135174,2021-10-05,Coated mesoporous nanoparticles,0,A61K
11129894,2021-09-28,Sensitizing cells to proton radiation,3,A61K|A61N|A61P
11124545,2021-09-21,"Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom",0,A61K|A61M|A61N|A61P|C07K|C12N|G01N
11123441,2021-09-21,Methods and compositions for drug delivery,0,A61K
11123440,2021-09-21,Compositions and methods for making antibody conjugates,1,A61K|C07K|C12N|C12Y
11119097,2021-09-14,Graphene-biomolecule bioelectronic devices,0,G01N
11118206,2021-09-14,Multiple stage isothermal enzymatic amplification,0,C12P|C12Q
11118185,2021-09-14,AAV vectors for treatment of dominant retinitis pigmentosa,1,A61P|C12N
11117942,2021-09-14,AAV-EPO for treating companion animals,0,A61K|A61P|C07K|C12N
11116838,2021-09-14,Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy,0,A61K|C07K|C12N|Y02A
11116795,2021-09-14,Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor,0,A61K|A61P|C07K|C12N
11103496,2021-08-31,Methods for enhancing liver regeneration,0,A61K|A61P
11098286,2021-08-24,Scalable purification method for AAV9,4,B01D|B01J|C12N|G01N
11096927,2021-08-24,Anti-flavivirus compounds and methods of use,5,A61K|A61P|Y02A
11091776,2021-08-17,AAV8 mutant capsids and compositions containing same,0,C07K|C12N
11091518,2021-08-17,"Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same",1,A61K|A61P|C07K|C12N
11090392,2021-08-17,Gene therapy for ocular disorders,0,A61K|A61P|C07K|C12N
11090387,2021-08-17,Hydrolytically degradable polysaccharide hydrogels,0,A61K|A61L|C12N
11090336,2021-08-17,Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy,2,A61K|A61P|C07K
11084880,2021-08-10,Anti-BCMA chimeric antigen receptor,8,A61K|A61P|C07H|C07K|C12N
11084848,2021-08-10,Artificial proteins and compositions and methods thereof,0,C07K|G01N
11078285,2021-08-03,Anti-TEM1 antibodies and uses thereof,0,A61K|A61P|C07K
11071746,2021-07-27,Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation,0,A61K|A61P
11066633,2021-07-20,Systems and methods for producing micro-engineered models of the human cervix,0,C12M|C12N
11065348,2021-07-20,Apparatus and methods for making recombinant protein-stabilized monodisperse microbubbles,0,A61B|A61K|A61N|B01F|C07K
11060107,2021-07-13,Purification and purity assessment of RNA molecules synthesized with modified nucleosides,12,A61K|C07H|C07K|C12N|C12P
11046721,2021-06-29,Ruthenium-based photolinkers and methods of use,0,B01J|C07F|C07H|C12N|C12Q
11045535,2021-06-29,"Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same",1,A61K|C07K|C12N|C12Y|Y02A
11041171,2021-06-22,Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby,1,A61K|A61P|C07K|C12N|C12Q|C12Y
11041012,2021-06-22,Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens,0,A61K|C07K|C12N
11040324,2021-06-22,Polyelectrolyte microcapsules and methods of making the same,0,A01N|A23L|A61K|A61Q|B01J|C11D
11035866,2021-06-15,Biomarkers for seizures,0,A61K|G01N
11034994,2021-06-15,In vivo detection of phospholipase activation,0,A61K|C12Q|G01N
11034977,2021-06-15,Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby,0,A61K|A61P|C07K|C12N|C12Q|C12Y
11034976,2021-06-15,Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby,0,A61K|A61P|C07K|C12N|C12Q|C12Y
11034749,2021-06-15,Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof,8,A61K|A61P|C07K|C12N
11033567,2021-06-15,5-aza-2′-deoxycytidine and methods of use thereof for promoting wound healing and regeneration,0,A61K|A61Q
11028389,2021-06-08,Methods for enhancing utrophin production via inhibition of microRNA,0,A61K|A61P|C12N
11028372,2021-06-08,Scalable purification method for AAVRH10,4,B01D|B01J|C12N|G01N
11028177,2021-06-08,Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells,1,A61K|A61P|C07K
11028143,2021-06-08,Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules,5,A61K|C07K|C12N|G01N|Y02A
11027011,2021-06-08,Vaccines with biomolecular adjuvants,0,A61K|A61P|C07K|C12N|Y02A
11027009,2021-06-08,Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same,0,A61K|A61P|C07K|C12N|Y02A
11026976,2021-06-08,Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain,2,A61K|A61P|C07K|C12N
11026945,2021-06-08,Protein kinase RNA-like endoplasmic reticulum kinase (PERK) inhibitors for prevention and/or treatment of lung injury and/or inflammation,0,A61K|A61P|C12N|C12Y
11021520,2021-06-01,"Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using the same",0,A61K|A61P|C07K|C12N
11021502,2021-06-01,Transcriptome in vivo analysis (TIVA) and transcriptome in situ analysis (TISA),0,B01J|C07F|C07H|C12N|C12Q
11020456,2021-06-01,Methods for modulating an inflammatory response,0,A61K|A61P|C07K|Y02A
11015174,2021-05-25,Scalable purification method for AAV8,6,B01D|B01J|C12N|G01N
11015173,2021-05-25,Scalable purification method for AAV1,4,B01D|B01J|C12N|G01N
11008546,2021-05-18,"Systems and methods for immobilizing extracellular matrix material on organ on chip, multilayer microfluidics microdevices, and three-dimensional cell culture systems",3,A61L|C08L|C12M|C12N|G01N|G09B
11007265,2021-05-18,Vaccines having an antigen and interleukin-21 as an adjuvant,0,A61K|A61N|A61P|C07K|C12N|Y02A
11007247,2021-05-18,Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers,0,A61K|C07K|C12N|Y02A
11001805,2021-05-11,ICOS critically regulates the expansion and function of inflammatory human Th17 cells,0,A61K|A61P|C12N
11001558,2021-05-11,Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy,2,A61K|A61P|C07D|Y02A
11000505,2021-05-11,Salvinorin compositions and uses thereof,0,A61K
10988519,2021-04-27,Composition and method for treating complement-mediated disease,1,A61K|A61P|C07K|C12N
10987433,2021-04-27,Compositions and methods for correction of heritable ocular disease,3,A61K|C12N
10987407,2021-04-27,Methods and compositions for treating hypoglycemic disorders,5,A61K|A61P
10983117,2021-04-20,Carbon nanotube biosensors and related methods,0,B82Y|G01N|Y02A|Y10S
10981969,2021-04-20,Switch costimulatory receptors,3,A61K|A61P|C07K
10980870,2021-04-20,"Proteins comprising MRSA Pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections",0,A61K|A61P|C07K|C12Q
10980820,2021-04-20,Compositions and methods for suppressing or reducing systemic immune response in a subject,0,A61K|A61P
10975140,2021-04-13,Compositions comprising AAV expressing dual antibody constructs and uses thereof,0,A61K|A61P|C07K|C12N
10973929,2021-04-13,Gene therapy for treating mucopolysaccharidosis type I,0,A61K|A61P|C12N|C12Y
10973928,2021-04-13,"Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor",5,A61K|A61P|C07K|C12N|C12Y
10973800,2021-04-13,Salvinorin compositions and uses thereof,0,A61K
10966995,2021-04-06,Use of secoisolariciresinol diglucosides (SDGS) and related compounds for protection against radiation and chemical damage,2,A61K
10961525,2021-03-30,Hyperactive AID/APOBEC and hmC dominant TET enzymes,0,C12N
10961288,2021-03-30,Isolated B7-H4 specific compositions and methods of use thereof,0,C07K|G01N
10961200,2021-03-30,Small molecule inhibitors of lactate dehydrogenase and methods of use thereof,4,A61K|A61P|C07D
10954228,2021-03-23,1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof,2,A61P|C07D
10953079,2021-03-23,Synthetic immunogens for prophylaxis or treatment of tuberculosis,0,A61K|A61P
10947561,2021-03-16,Method of increasing the function of an AAV vector,0,A61K|A61P|C07K|C12N
10947290,2021-03-16,Method of stabilizing a bioactive peptide against protease hydrolysis,0,A61K|C07K
10946042,2021-03-16,Compositions and methods for selective phagocytosis of human cancer cells,0,A61K|C12N
10941452,2021-03-09,Compositions and methods for isolation of circulating tumor cells (CTC),0,C07H|C12N|C12Q|G01N
10940217,2021-03-09,Polyphosphazene delivery system for inorganic nanocrystals,1,A61B|A61K|A61N
10934336,2021-03-02,Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy,6,A61K|A61P|C07K
10933130,2021-03-02,Vaccines with interleukin-33 as an adjuvant,0,A61K|A61P|C07K|C12N|Y02A
10927184,2021-02-23,Treatment of cancer using humanized anti-CD19 chimeric antigen receptor,5,A61K|A61P|C07K|C12N
10925961,2021-02-23,Vaccines with CD40 ligand as an adjuvant,0,A61K|A61P|C07K|C12N|Y02A
10921326,2021-02-16,Fluorescent labeling of transfer RNA and study of protein synthesis,0,C12P|C12Q|G01N
10920244,2021-02-16,Compositions for targeting conducting airway cells comprising adeno-associated virus constructs,0,A61K|A61P|C07K|C12N
10918658,2021-02-16,Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer,0,A61K|A61P|C12N
10908069,2021-02-02,In situ tribometer and methods of use,7,G01N|G01Q
10905755,2021-02-02,Vaccines for human papilloma virus and methods for using the same,0,A61K|A61N|A61P|C07K|C12N|Y02A
